Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321378672> ?p ?o ?g. }
- W4321378672 endingPage "763" @default.
- W4321378672 startingPage "756" @default.
- W4321378672 abstract "Genetic variants in regions that include the mitochondrial genes thioredoxin reductase 2 (TXNRD2) and malic enzyme 3 (ME3) are associated with primary open-angle glaucoma (POAG) in genome-wide association studies (GWASs). To assess their clinical impact, we investigated whether TXNRD2 and ME3 genetic risk scores (GRSs) are associated with specific glaucoma phenotypes.Cross-sectional study.A total of 2617 patients with POAG and 2634 control participants from the National Eye Institute Glaucoma Human Genetics Collaboration Hereditable Overall Operational Database (NEIGHBORHOOD) consortium.All POAG-associated single nucleotide polymorphisms (SNPs) in the TXNRD2 and ME3 loci were identified using GWAS data (P < 0.05). Of these, 20 TXNRD2 and 24 ME3 SNPs were selected after adjusting for linkage disequilibrium. The correlation between SNP effect size and gene expression levels was investigated using the Gene-Tissue Expression database. Genetic risk scores were constructed for each individual using the unweighted sum of TXNRD2, ME3, and TXNRD2 + ME3 combined risk alleles. Age- and sex-adjusted odds ratios (ORs) for POAG diagnosis were calculated per decile for each GRS. Additionally, the clinical features of patients with POAG in the top 1%, 5%, and 10% of each GRS were compared with those in the bottom 1%, 5%, and 10%, respectively.Primary open-angle glaucoma OR per GRS decile, maximum treated intraocular pressure (IOP), and prevalence of paracentral visual field loss among patients with POAG with high versus low GRSs.A larger SNP effect size strongly correlated with higher TXNRD2 and lower ME3 expression levels (r = 0.95 and r = -0.97, respectively; P < 0.05 for both). Individuals in decile 10 of the TXNRD2 + ME3 GRS had the highest odds of POAG diagnosis (OR, 1.79 compared with decile 1; 95% confidence interval, 1.39-2.30; P < 0.001). Patients with POAG in the top 1% of the TXNRD2 GRS showed higher mean maximum treated IOP compared with the bottom 1% (19.9 mmHg vs. 15.6 mmHg; adjusted P = 0.03). Patients with POAG in the top 1% of the ME3 and TXNRD2 + ME3 GRS showed a higher prevalence of paracentral field loss than the bottom 1% (72.7% vs. 14.3% for ME3 GRS and 88.9% vs. 33.3% for TXNRD2+ME3 GRS; adjusted P = 0.03 for both).Patients with POAG with higher TXNRD2 and ME3 GRSs showed higher treated IOP and a greater prevalence of paracentral field loss. Functional studies exploring how these variants impact mitochondrial function in patients with glaucoma are warranted.Proprietary or commercial disclosure may be found after the references." @default.
- W4321378672 created "2023-02-21" @default.
- W4321378672 creator A5007043815 @default.
- W4321378672 creator A5010480125 @default.
- W4321378672 creator A5011523562 @default.
- W4321378672 creator A5012599011 @default.
- W4321378672 creator A5013606180 @default.
- W4321378672 creator A5016062031 @default.
- W4321378672 creator A5017757731 @default.
- W4321378672 creator A5019252348 @default.
- W4321378672 creator A5020266650 @default.
- W4321378672 creator A5020478009 @default.
- W4321378672 creator A5021614460 @default.
- W4321378672 creator A5023951303 @default.
- W4321378672 creator A5027121559 @default.
- W4321378672 creator A5028734865 @default.
- W4321378672 creator A5030747987 @default.
- W4321378672 creator A5036560468 @default.
- W4321378672 creator A5040284130 @default.
- W4321378672 creator A5040841311 @default.
- W4321378672 creator A5042155954 @default.
- W4321378672 creator A5043994887 @default.
- W4321378672 creator A5050960501 @default.
- W4321378672 creator A5051524591 @default.
- W4321378672 creator A5057271336 @default.
- W4321378672 creator A5059589308 @default.
- W4321378672 creator A5061016246 @default.
- W4321378672 creator A5062127850 @default.
- W4321378672 creator A5062252450 @default.
- W4321378672 creator A5063659153 @default.
- W4321378672 creator A5065246588 @default.
- W4321378672 creator A5066474989 @default.
- W4321378672 creator A5069324665 @default.
- W4321378672 creator A5074370153 @default.
- W4321378672 creator A5086641481 @default.
- W4321378672 creator A5088012092 @default.
- W4321378672 creator A5090027463 @default.
- W4321378672 creator A5090443674 @default.
- W4321378672 creator A5090607289 @default.
- W4321378672 date "2023-07-01" @default.
- W4321378672 modified "2023-09-25" @default.
- W4321378672 title "Mitochondrial TXNRD2 and ME3 Genetic Risk Scores Are Associated with Specific Primary Open-Angle Glaucoma Phenotypes" @default.
- W4321378672 cites W1865845132 @default.
- W4321378672 cites W1993379925 @default.
- W4321378672 cites W2003895213 @default.
- W4321378672 cites W2037652817 @default.
- W4321378672 cites W2052058687 @default.
- W4321378672 cites W2123411711 @default.
- W4321378672 cites W2138558536 @default.
- W4321378672 cites W2168136778 @default.
- W4321378672 cites W2185652905 @default.
- W4321378672 cites W2265638154 @default.
- W4321378672 cites W2508514063 @default.
- W4321378672 cites W2532281394 @default.
- W4321378672 cites W2765466415 @default.
- W4321378672 cites W2803323905 @default.
- W4321378672 cites W2916333363 @default.
- W4321378672 cites W2969585998 @default.
- W4321378672 cites W2982158520 @default.
- W4321378672 cites W3000547714 @default.
- W4321378672 cites W3045788107 @default.
- W4321378672 cites W3131963404 @default.
- W4321378672 cites W3133859624 @default.
- W4321378672 cites W3214731393 @default.
- W4321378672 cites W4205927983 @default.
- W4321378672 cites W4210660885 @default.
- W4321378672 cites W4308685723 @default.
- W4321378672 doi "https://doi.org/10.1016/j.ophtha.2023.02.018" @default.
- W4321378672 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36813040" @default.
- W4321378672 hasPublicationYear "2023" @default.
- W4321378672 type Work @default.
- W4321378672 citedByCount "1" @default.
- W4321378672 countsByYear W43213786722023 @default.
- W4321378672 crossrefType "journal-article" @default.
- W4321378672 hasAuthorship W4321378672A5007043815 @default.
- W4321378672 hasAuthorship W4321378672A5010480125 @default.
- W4321378672 hasAuthorship W4321378672A5011523562 @default.
- W4321378672 hasAuthorship W4321378672A5012599011 @default.
- W4321378672 hasAuthorship W4321378672A5013606180 @default.
- W4321378672 hasAuthorship W4321378672A5016062031 @default.
- W4321378672 hasAuthorship W4321378672A5017757731 @default.
- W4321378672 hasAuthorship W4321378672A5019252348 @default.
- W4321378672 hasAuthorship W4321378672A5020266650 @default.
- W4321378672 hasAuthorship W4321378672A5020478009 @default.
- W4321378672 hasAuthorship W4321378672A5021614460 @default.
- W4321378672 hasAuthorship W4321378672A5023951303 @default.
- W4321378672 hasAuthorship W4321378672A5027121559 @default.
- W4321378672 hasAuthorship W4321378672A5028734865 @default.
- W4321378672 hasAuthorship W4321378672A5030747987 @default.
- W4321378672 hasAuthorship W4321378672A5036560468 @default.
- W4321378672 hasAuthorship W4321378672A5040284130 @default.
- W4321378672 hasAuthorship W4321378672A5040841311 @default.
- W4321378672 hasAuthorship W4321378672A5042155954 @default.
- W4321378672 hasAuthorship W4321378672A5043994887 @default.
- W4321378672 hasAuthorship W4321378672A5050960501 @default.
- W4321378672 hasAuthorship W4321378672A5051524591 @default.
- W4321378672 hasAuthorship W4321378672A5057271336 @default.
- W4321378672 hasAuthorship W4321378672A5059589308 @default.